Completed OBSERVATIONAL NCT03690180

Hypomagnesemia and Diabetic Nephropathy

Hypomagnesemia as a Marker of Diabeteiv Nephropathy

Sponsor: Fayoum University

Updated 6 times since 2018 Last updated: Sep 6, 2019 Started: Jan 1, 2018 Primary completion: Jan 30, 2018 Completion: Feb 28, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Diabetic Nephropathies and is currently completed. Fayoum University leads this study, which shows 6 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Oct 2019 — Jan 2021 [monthly]

Completed

▶ Show 1 earlier version

Nov 2018 — Oct 2019 [monthly]

Completed

First recorded

Jan 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fayoum University

Data source: Fayoum University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Al Fayyum, Egypt